Stay updated on Tesofensine/Metoprolol in Type 2 Diabetes Clinical Trial

Sign up to get notified when there's something new on the Tesofensine/Metoprolol in Type 2 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tesofensine/Metoprolol in Type 2 Diabetes Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Type 2 Diabetes Mellitus and the related MedlinePlus Genetics topics are removed. This reduces the page’s explicit focus and relevant navigational context for users seeking information about the study.
    Difference
    0.2%
    Check dated 2025-12-30T18:36:38.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Footer shows Revision: v3.3.3; the HHS Vulnerability Disclosure and Revision: v3.3.2 items were removed. No study content, eligibility criteria, or results were modified.
    Difference
    0.1%
    Check dated 2025-12-23T17:24:48.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Added related topics 'Type 2 diabetes' and 'MedlinePlus Genetics' to the study page to provide auxiliary references. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-16T04:37:52.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Type 2 Diabetes Mellitus and the related topic link MedlinePlus Genetics were removed from the page's Conditions and Related Topics sections. This reduces visibility of the study's disease focus and related reference links, potentially impacting discoverability by disease-related searches.
    Difference
    0.2%
    Check dated 2025-12-09T01:35:45.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page's revision metadata was updated to v3.3.2; the previous v3.2.0 entry was removed.
    Difference
    0.1%
    Check dated 2025-11-24T21:18:54.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page no longer displays a government funding lapse notice regarding NIH operations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T18:33:10.000Z thumbnail image

Stay in the know with updates to Tesofensine/Metoprolol in Type 2 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tesofensine/Metoprolol in Type 2 Diabetes Clinical Trial page.